 |
|
The Efficacy of UGT1A1 Polymorphism in Chemoradiation Therapy Using Irinotecan in Patients with Locally Advanced Rectal Cancer.
Oh, Seung Yeop , Kim, Young Bae , Chun, Mi Son , Suh, Kwang Wook
J Korean Soc Coloproctol. 2007;23(5):344-349. DOI: https://doi.org/10.3393/jksc.2007.23.5.344
|
|
Citations to this article as recorded by
 The UGT1A9*22 genotype identifies a high-risk group for irinotecan toxicity among gastric cancer patients
Choong-kun Lee, Hong Jae Chon, Woo Sun Kwon, Hyo-Jeong Ban, Sang Cheol Kim, Hyunwook Kim, Hei-Cheul Jeung, Jimyung Chung, Sun Young Rha
Genomics & Informatics.2022; 20(3): e29. CrossRef Pretreatment selection of regimen according to genetic analysis improves the efficacy of chemotherapy in the first line treatment of metastatic colorectal cancer
Do Yoon Kim, Tae Yoon Paek, Seung Yeop Oh, Young Bae Kim, Je Hee Lee, Mi Young Lee, Zi Sun Choi, Kwang Wook Suh
Journal of Surgical Oncology.2014; 109(3): 250. CrossRef
|